SEC Form 4 · accession 0001144204-19-002893
Checkpoint Therapeutics, Inc. · CKPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Garrett Gray
Officer — See Remarks
Period of report
Jan 24, 2019
Accepted (ET)
Jan 25, 2019 · 4:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651407
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK (RESTRICTED)F1,F2 | Jan 24, 2019 | A | 90,000 | $0.00 | A | 220,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares of restricted stock vest as follows: one-half on January 24, 2021, one-fourth on January 24, 2022, and one-fourth on January 24, 2023.
- F2Includes 50,000 shares of restricted stock that were granted on March 2, 2016, as previously reported, and will vest as follows: (i) 33,334 shares vest on March 2, 2019; and (ii) 16,666 shares vest on March 2, 2020. Also includes 30,000 shares of restricted stock that were granted on December 15, 2016, as previously reported, and will vest as follows: (i) 22,500 shares vest on December 15, 2019; and (ii) 7,500 shares vest on December 15, 2020. Also includes 50,000 shares of restricted stock that were granted on January 30, 2018, as previously reported, and will vest as follows: (i) 25,000 shares vest on January 30, 2020; (ii) 12,500 shares vest on January 20, 2021; and (iii) 12,500 shares vest on January 30, 2022. Also includes 90,000 shares of restricted stock that were granted on January 24, 2019, as reported herein, and will vest as follows: (i) 45,000 shares vest on January 24, 2021; (ii) 22,500 shares vest on January 24, 2022; and (iii) 22,500 shares vest on January 24, 2023.
Remarks
Principal Financial Officer, VP Finance and Accounting